Everence Capital Management Inc. Sells 2,800 Shares of The Clorox Company (NYSE:CLX)

Everence Capital Management Inc. cut its holdings in shares of The Clorox Company (NYSE:CLX) by 39.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,350 shares of the company’s stock after selling 2,800 shares during the quarter. Everence Capital Management Inc.’s holdings in Clorox were worth $620,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of CLX. Norges Bank bought a new stake in shares of Clorox in the 4th quarter valued at about $101,609,000. Imprint Wealth LLC raised its holdings in shares of Clorox by 16,986.8% in the 2nd quarter. Imprint Wealth LLC now owns 551,392 shares of the company’s stock valued at $55,139,000 after purchasing an additional 548,165 shares during the period. Qube Research & Technologies Ltd raised its holdings in shares of Clorox by 75.9% in the 3rd quarter. Qube Research & Technologies Ltd now owns 1,130,481 shares of the company’s stock valued at $148,161,000 after purchasing an additional 487,974 shares during the period. International Assets Investment Management LLC raised its holdings in shares of Clorox by 17,658.5% in the 4th quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock valued at $69,078,000 after purchasing an additional 481,725 shares during the period. Finally, Acadian Asset Management LLC raised its holdings in shares of Clorox by 39.6% in the 3rd quarter. Acadian Asset Management LLC now owns 1,467,713 shares of the company’s stock valued at $192,319,000 after purchasing an additional 415,999 shares during the period. 78.53% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently commented on CLX shares. The Goldman Sachs Group started coverage on shares of Clorox in a research note on Friday, March 1st. They issued a “sell” rating and a $140.00 price target on the stock. Citigroup decreased their price target on shares of Clorox from $165.00 to $155.00 and set a “neutral” rating on the stock in a research note on Tuesday. Barclays decreased their price target on shares of Clorox from $148.00 to $136.00 and set an “underweight” rating on the stock in a research note on Wednesday, April 10th. JPMorgan Chase & Co. upped their price target on shares of Clorox from $145.00 to $152.00 and gave the company a “neutral” rating in a research note on Thursday, January 18th. Finally, Morgan Stanley restated an “equal weight” rating and set a $160.00 target price on shares of Clorox in a research report on Tuesday, March 26th. Four research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $148.63.

Clorox Stock Performance

NYSE CLX opened at $142.29 on Thursday. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37. The firm has a market capitalization of $17.66 billion, a price-to-earnings ratio of 225.86, a P/E/G ratio of 2.22 and a beta of 0.43. The firm’s 50 day simple moving average is $150.40 and its 200 day simple moving average is $141.69. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $178.21.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $1.08. The business had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.80 billion. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The firm’s revenue for the quarter was up 16.0% on a year-over-year basis. During the same quarter last year, the business posted $0.98 EPS. As a group, research analysts expect that The Clorox Company will post 5.52 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be paid a $1.20 dividend. This represents a $4.80 annualized dividend and a yield of 3.37%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox’s payout ratio is 761.92%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.